Efficiency of 3D-printed Implant Versus Autograft for Orbital Reconstruction (TOR-3D)

Recruiting N/A Interventional Study
Significant Bone Defect in the Orbit
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
92 (estimated)
Sponsor
Hospices Civils de Lyon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Two scenarios may result in significant bone defect in the orbit: surgical oncology (meningioma, cancers of the upper aerodigestive tract) or severe trauma. This defect in the bone substance may affect the orbital floor, medial wall or lateral wall. These injuries can result in functional complications such as enophthalmos and diplopia, and an esthetic impact affecting the quality of life. The mos…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient between 18 to 90 years old * Presenting a defect in the bone substance of an orbital wall (floor, lateral or medial): at least 6 months following a oncologic surgery (in particular meningioma or carcinoma of the upper aerodigestive tract) OR post-traumatic; * With a de…
Contacts

Jean-Thomas BACHELET

+33 4 26 73 26 44

jean-thomas.bachelet@chu-lyon.fr

CONTACT

Magali HANSER

+33 4 72 11 57 65

magali.hanser@chu-lyon.fr

CONTACT